Spectrum Pharmaceuticals, Inc. (SPPI) Social Stream
SPECTRUM PHARMACEUTICALS INC (SPPI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SPECTRUM PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 3 | $10 | $3 | $6.75 | $1.03 | 555.34% |
| 2022-01-06 | 4 | $10 | $3 | $6.75 | $1.03 | 555.34% |
| 2022-03-18 | 4 | $10 | $3 | $6.5 | $1.03 | 531.07% |
| 2022-05-19 | 4 | $10 | $3 | $6 | $1.03 | 482.52% |
| 2022-08-15 | 4 | $10 | $3.001 | $6 | $1.03 | 482.52% |
| 2022-09-12 | 4 | $12 | $3.001 | $6.5 | $1.03 | 531.07% |
| 2022-09-20 | 4 | $9 | $3.001 | $5.75 | $1.03 | 458.25% |
| 2022-09-23 | 4 | $9 | $1.5 | $4.25 | $1.03 | 312.62% |
| 2022-11-11 | 4 | $6 | $1.5 | $3.5 | $1.03 | 239.81% |
| 2022-11-16 | 4 | $6 | $1 | $3.375 | $1.03 | 227.67% |
| 2022-11-28 | 4 | $4 | $1 | $2.875 | $1.03 | 179.13% |
| 2023-01-31 | 5 | $4 | $1 | $2.875 | $1.03 | 179.13% |
| 2023-02-01 | 5 | $4 | $1 | $3.1 | $1.03 | 200.97% |
| 2023-03-23 | 5 | $4 | $0.75 | $2.312 | $1.03 | 124.47% |
| 2023-04-26 | 5 | $4 | $1 | $2.41 | $1.03 | 133.98% |
| 2023-05-05 | 5 | $4 | $1.14 | $2.445 | $1.03 | 137.38% |
| 2023-07-11 | 5 | $4 | $1.14 | $1.945 | $1.03 | 88.83% |
The Trend in the Analyst Price Target
Over the past 24 months, SPPI's average price target has gone down $7.86.
Over the past 48 weeks, SPPI's average upside potential has been 387.83%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-12 | 4 | 10 | 3.001 | 6.000 | 1.36 | 341.18% |
| 2022-09-12 | 4 | 12 | 3.001 | 6.500 | 1.26 | 415.87% |
| 2023-02-01 | 5 | 4 | 1.000 | 3.100 | 0.85 | 264.71% |
| 2023-05-15 | 5 | 4 | 1.140 | 1.945 | 1.25 | 55.6% |
| 2023-07-11 | 5 | 4 | 1.140 | 1.945 | 0.94 | 106.91% |
SPPI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 5 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
SPPI's average broker recommendation rating worsened by 1.33 over the prior 22 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SPPI has a higher average analyst price target than 69.97% of all US stocks.
- In the context of stocks in the mid market cap category, SPECTRUM PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1722.52% of them.
- SPPI has a greater upside potential (average analyst target price relative to current price) than 1811.21% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, SPECTRUM PHARMACEUTICALS INC's number of analysts covering the stock is greater than 315.84% of them.
In the Pharmaceutical Products industry, HRTX, ADCT, and ROIV are the three stocks most similar to SPECTRUM PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is SPPI a Buy, Hold or Sell? See the POWR Ratings now!